代謝機能障害に関連するステアトヘパチス患者における運動
1Fatty Liver Program Director, Penn State Health Liver Center Director of Research, Penn State Health Associate Professor of Medicine and Public Health Sciences Division of Gastroenterology & Hepatology Department of Medicine Penn State Health Milton S. Hershey Medical Center Hershey, Pennsylvania.
Gastroenterology & hepatology
|September 2, 2025
まとめ
No abstract available in PubMed .
さらに関連する動画
関連する概念動画
01:29Chronic Pancreatitis II: Collaborative Care
128
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
128
01:26Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33